Clinical trial · Observational
EVEREST-HN 1: EVolution of a patiEnt-REported Symptom-based Risk Stratification sySTem
EVolution of a patiEnt-REported Symptom-based Risk Stratification sySTem to Redesign the Suspected Head and Neck Cancer Referral Pathway (Phase 1)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Can a patient-reported symptom-based risk stratification system improve the suspected head and neck cancer (HNC) pathway? Our methodology includes six interlinked work packages to deliver our aim, with EVEREST-HN 1 encompassing the first of these and seeking to optimise a patient-reported symptom inventory for HNC and outline requirement specification for the SYmptom iNput Clinical (SYNC) system.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No intervention. | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Patients
- description
- Approximately 150 adults referred for suspected HNC will be recruited.
- interventionNames
- Other: No intervention.
- label
- Staff
- description
- Approximately 15 ENT and Maxillofacial) clinicians will be recruited.
- interventionNames
- Other: No intervention.
Primary outcomes (1)
- measure
- Inventory and specification for the SYmptom iNput Clinical (SYNC) system
- timeFrame
- September 2022 - August 2023
- description
- To optimise a patient-reported symptom inventory for HNC and outline requirement specification for the SYmptom iNput Clinical (SYNC) system
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Patients: * Adults ≥ 18 years referred via suspected HNC pathway without previous history of HNC * Participants willing and able to give informed consent for participation in the study. Clinicians: * Staff at participating sites involved in the diagnostic pathway for people with suspected HNC. Exclusion Criteria: * Individuals who do not meet the inclusion criteria.
References
Publications (0)
Data not yet available